2023 | Acetate-Mediated Odorant Receptor OR51E2 Activation Results in Calcitonin Secretion in Parafollicular C-Cells: A Novel Diagnostic Target of Human Medullary Thyroid Cancer
| BIOMEDICINES |
2023 | 18F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models
| JOURNAL OF NUCLEAR MEDICINE |
2023 | Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
| JOURNAL OF GASTRIC CANCER |
2022 | Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea
| THORACIC CANCER |
2022 | Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity
| JOURNAL OF CLINICAL INVESTIGATION |
2022 | Profile of vascular markers and CT enhancement of hyaline vascular type Castleman's disease | MICROVASCULAR RESEARCH |
2022 | Altered Glucose Metabolism and Glucose Transporters in Systemic Organs After Bariatric Surgery
| FRONTIERS IN ENDOCRINOLOGY |
2022 | Prognosis Associated with Glycolytic Activity in Regional Lymph Nodes of Patients with Previously Untreated Metastatic Breast Cancer: A Preliminary Study
| DIAGNOSTICS |
2022 | Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells
| CELL REPORTS |
2022 | Predicting treatment outcomes using 18 F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
2021 | Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment | GUT |
2021 | STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [ 18 F]FLT PET imaging
| PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
2021 | Splenic uptake on FDG PET/CT correlates with Kikuchi-Fujimoto disease severity
| SCIENTIFIC REPORTS |
2021 | Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2021 | Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative 18 F-FDG PET/CT in patients with localized primary gastrointestinal stromal tumors
| CANCER & METABOLISM |
2020 | Altered systematic glucose utilization after gastrectomy: correlation with weight loss | SURGERY FOR OBESITY AND RELATED DISEASES |
2020 | Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer | LUNG CANCER |
2020 | Clinicopathologic risk factors of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective cohort study | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2020 | Metabolic Modifier Screen Reveals Secondary Targets of Protein Kinase Inhibitors within Nucleotide Metabolism
| CELL CHEMICAL BIOLOGY |
2019 | The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer.
| GASTRIC CANCER |
2018 | Evaluation of 18F-FDG PET/CT Parameters for Detection of Lymph Node Metastasis in Cutaneous Melanoma
| NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2018 | Regulation of Acetate Utilization by Monocarboxylate Transporter 1 (MCT1) in Hepatocellular Carcinoma (HCC). | ONCOLOGY RESEARCH |
2018 | The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status | GASTRIC CANCER |
2017 | Usefulness of SPECT/CT in Parathyroid Lesion Detection in Patients with Thyroid Parenchymal 99mTc-Sestamibi Retention
| NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2017 | Correlation between KRAS mutation and 18F-FDG uptake in stage IV colorectal cancer | ABDOMINAL RADIOLOGY |
2017 | Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2017 | Intestinal Glycolysis Visualized by FDG PET/CT Correlates With Glucose Decrement After Gastrectomy | DIABETES |
2017 | Feasibility of Preoperative FDG PET/CT Total Hepatic Glycolysis in the Remnant Liver for the Prediction of Postoperative Liver Function | AMERICAN JOURNAL OF ROENTGENOLOGY |
2017 | Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents | CLINICAL NUCLEAR MEDICINE |
2016 | Increased hepatic FDG uptake on PET/CT in hepatic sinusoidal obstructive syndrome
| ONCOTARGET |
2016 | Prognostic Value of Volumetric Parameters on Staging and Posttreatment FDG PET/CT in Patients With Stage IV Non-Small Cell Lung Cancer | CLINICAL NUCLEAR MEDICINE |
2016 | Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma. | ANNALS OF NUCLEAR MEDICINE |
2016 | Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer. | TUMOR BIOLOGY |
2016 | Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.
| BMC CANCER |
2016 | Prognostic Impact of Ultrasonography Features and (18)F-Fluorodeoxyglucose Uptake in Patients With Papillary Thyroid Microcarcinoma | CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY |
2016 | A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
| CANCER RESEARCH AND TREATMENT |
2016 | Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer | ANNALS OF NUCLEAR MEDICINE |
2016 | Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy | PHARMACOGENETICS AND GENOMICS |
2016 | Synergic chemoprevention with dietary carbohydrate restriction and supplementation of AMPK-activating phytochemicals: the role of SIRT1
| EUROPEAN JOURNAL OF CANCER PREVENTION |
2016 | Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters. | CLINICAL NUCLEAR MEDICINE |
2015 | Correlation Analysis and Prognostic Impact of (18)F-FDG PET and Excision Repair Cross-Complementation Group 1 (ERCC-1) Expression in Non-Small Cell Lung Cancer
| NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2015 | Association Between Choroidal Thickness and Metabolic Activity on Positron Emission Tomography in Eyes With Choroidal Melanoma | AMERICAN JOURNAL OF OPHTHALMOLOGY |
2015 | Prognostic value of pretreatment FDG PET in pediatric neuroblastoma | EUROPEAN JOURNAL OF RADIOLOGY |
2015 | Predictive value of bone scintigraphy for the detection of joint involvement in Behçet's disease: Dermatologists' perspectives | EUROPEAN JOURNAL OF DERMATOLOGY |
2015 | Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors
| PLOS ONE |
2015 | Thyroid incidentalomas detected on (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients | SURGERY |
2015 | Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer | JOURNAL OF NUCLEAR MEDICINE |
2015 | (18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging | NUCLEAR MEDICINE AND BIOLOGY |
2015 | 64Cu-ATSM Hypoxia Positron Emission Tomography for Detection of Conduit Ischemia in an Experimental Rat Esophagectomy Model
| PLOS ONE |
2015 | The performance of contrast-enhanced FDG PET/CT for the differential diagnosis of unexpected ovarian mass lesions in patients with nongynecologic cancer | CLINICAL NUCLEAR MEDICINE |